| 注册
首页|期刊导航|中国医学创新|子宫内膜息肉术后复发危险因素及治疗研究进展

子宫内膜息肉术后复发危险因素及治疗研究进展

唐玫 郭晓青 侯红叶 刘娜娜

中国医学创新2025,Vol.22Issue(5):179-183,5.
中国医学创新2025,Vol.22Issue(5):179-183,5.DOI:10.3969/j.issn.1674-4985.2025.05.042

子宫内膜息肉术后复发危险因素及治疗研究进展

Progress in the Study of Postoperative Recurrence Risk Factors and Treatment of Endometrial Polyps

唐玫 1郭晓青 2侯红叶 1刘娜娜1

作者信息

  • 1. 甘肃中医药大学中西医结合学院 甘肃 兰州 730000
  • 2. 甘肃中医药大学附属医院妇产科 甘肃 兰州 730030
  • 折叠

摘要

Abstract

Endometrial polyp(EP)is a local stromal overgrowth covered by benign glandular epithelium in the uterus,which is a common gynecological disease.It is often clinically manifested as abnormal uterine bleeding.Currently,the treatment of EP is mainly based on surgery,which can remove the ectopic lesion,relieve clinical symptoms and improve the pregnancy rate of women of reproductive age,but the high recurrence rate after surgery has become a difficult clinical problem to be solved,and the prevention or reduction of postoperative recurrence rate is also a new direction that needs to be explored in depth.The presence of some risk factors may affect the patients'prognosis,mainly including age,number of polyps,hormone level,body mass index(BMI),comorbid gynecological diseases,molecular biological factors,gene-related,follow-up time,and timely and standardized use of oral short-acting contraceptives after surgery is a protective factor for postoperative recurrence after EP.Postoperative patients after EP need to be managed in the long term,and the different postoperative treatments each have their own advantages and applicable scenarios that can improve the patients'prognosis.In this article,the risk factors and postoperative treatments for postoperative recurrence after EP resection are reviewed to provide a basis for the prevention and treatment of postoperative recurrence of EP.

关键词

子宫内膜息肉/复发/危险因素/治疗

Key words

Endometrial polyps/Recurrence/Risk factors/Treatment

引用本文复制引用

唐玫,郭晓青,侯红叶,刘娜娜..子宫内膜息肉术后复发危险因素及治疗研究进展[J].中国医学创新,2025,22(5):179-183,5.

基金项目

甘肃省卫生健康行业科研项目(GSWSKY2003-75) (GSWSKY2003-75)

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文